Atyr Pharma Inc

ATYRNASDAQ · USD
0.29USD0.00 (-2.94%)
332

Atyr Pharma Inc (ATYR) Unusual Options Activity Today

ATYR options volume power reached 1x on the previous trading day. The highest reading was on the $0.5 PUT expiring 2027-02-19.

Read more

Checking ATYR unusual options activity helps you spot when traders are making outsized bets on Atyr Pharma Inc before the broader market catches on. Atyr Pharma Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ATYR unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ATYR unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ATYR unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ATYR unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders.

It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Catalysts rarely arrive without a footprint, and ATYR unusual options activity is often where that footprint shows up first. Our scanner tracks Atyr Pharma Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ATYR unusual options volume on the call side or chasing put sweeps, Atyr Pharma Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
0.50—0.050.05398%2792.53%
1.00—0.050.05584%060.00%
1.50—0.050.05676%00—
2.00—0.650.651,000%00—
3.00—0.650.651,000%00—
Puts
0.500.150.200.1824%1911.11%
1.000.400.800.6048%10—
1.500.801.651.23567%00—
2.001.352.101.73630%10—
3.002.253.202.73716%00—

As of September 30, 2026

Spot unusual options activity before it moves

Track ATYR options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial